News

Become a Parkinson’s Care Advocate: Join Our Aware in Care Ambassador Pilot Program

When hospitalized, three out of every four people with Parkinson’s disease (PD) do not receive their medications on time. Most develop serious complications as a result. In 2011, the Parkinson’s Foundation launched Aware in Care to help people with Parkinson’s get the best care possible during a hospital stay, and it worked. Surprisingly, 70% of hospital staff are still unaware of…

Continue Reading

News

Notes from the CEO: Parkinson’s Foundation Earns 4-Star Rating from Charity Navigator

John Lehr, Parkinson’s Foundation CEO, shares the exciting news that the Parkinson’s Foundation has earned a 4-star rating from Charity Navigator and why this motivates us to continue making life better for people with Parkinson’s. “It means that we exceed industry standards through exceptional performance and accountability,” John said. ​ Learn more about the Parkinson’s Foundation 4-Star Charity Navigator rating now.…

Continue Reading

News

What’s Hot in PD? Should I Get an Appendectomy to Prevent Parkinson’s Disease?

In this week’s issue of Science Translational Medicine, Bryan Killinger, PhD, and colleagues examined the question, “Will removing my appendix impact my risk of later developing Parkinson’s disease (PD)?” Interestingly, several recent studies have attempted to answer this question. With the emerging evidence supporting that a gut-brain connection and interaction may play a potential role in Parkinson’s, this subject is…

Continue Reading

News

Realizing the potential of gene therapy for neurological disorders

Promising findings from preclinical animal studies show the potential of gene therapy for treating incurable neurological disorders. Scientists have successfully used gene therapy to slow the progression and improve symptoms of disorders such as amyotrophic lateral sclerosis and Parkinson’s disease. from Parkinson’s News — ScienceDaily https://ift.tt/2SMiCUN

News

Cooling ‘brains on fire’ to treat Parkinson’s

A promising new therapy to stop Parkinson’s disease in its tracks has been developed by scientists who found that a small molecule, MCC950, stopped the development of Parkinson’s in several animal models. The team hope to commence human clinical trials in 2020. from Parkinson’s News — ScienceDaily https://ift.tt/2qqaRHf